The opposition to Pembient in 2015 was not only rhetorical. It rested on a specific empirical claim: that demand for rhino horn in China and Vietnam was, in its dominant form, medicinal. The institutional case followed from that premise. If demand is medicinal, then synthetic alternatives risk normalizing the medicine. If demand is medicinal, demand-reduction campaigns aimed at debunking medicinal claims are the right strategy. If demand is medicinal, a market-flooding approach threatens the only intervention that works.
The peer-reviewed, primary-source record of what demand actually consisted of tells a different story. Researchers working in the Chinese-language record, in auction data, in consumer surveys, and in customs seizures find a market shaped by investment value, collectible value, status display, and artistic carving traditions, alongside medicinal use. Vietnamese demand has its own profile, distinct again. The market the institutional opposition described in 2015 was not the market the empirical record described.
This thread collects studies documenting the gap. The entries here are not about who said what about Pembient. They are about what the conservation establishment was defending when it argued that synthetic horn would expand demand. The frame presumed a market it had not described accurately. The studies in this thread describe it.
